Catalyst Wire Dossier Catalyst Wire Dossier

Goofice

Elobixibat · Synmosa Biopharma Corp.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Goofice, covering 2023-06-09 to 2023-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation [Phase 3]

See pricing